{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:07:56Z","timestamp":1778792876697,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014387","name":"Acadia Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bmcl.2026.130662","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:20:59Z","timestamp":1776468059000},"page":"130662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of novel SSRIs for a combination-treatment with pimavanserin"],"prefix":"10.1016","volume":"137","author":[{"given":"Annika","family":"Kers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1lint","family":"Gabos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Borhade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emelie","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Wellmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofi","family":"Gummeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Dreisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Sk\u00f6ld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"John A.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan S.","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130662_bb0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmcl.2026.130662_bb0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/jpn.0427","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.bmcl.2026.130662_bb0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tips.2007.10.009","article-title":"Important messages in the \u201cpost\u201d: recent discoveries in 5-HT neurone feedback control","volume":"28","author":"Sharp","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmcl.2026.130662_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.08.009","article-title":"Evaluation of 5-HT2A and mGlu2\/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment","volume":"86","author":"Muguruza","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmcl.2026.130662_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bmcl.2026.130662_bb0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","article-title":"Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders","volume":"28","author":"Marek","year":"2003","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.bmcl.2026.130662_bb0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1176\/appi.ajp.158.1.131","article-title":"A novel augmentation strategy for treating resistant major depression","volume":"158","author":"Shelton","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bmcl.2026.130662_bb0040","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/jpet.105.097006","article-title":"Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N\u2019-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2: 1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist","volume":"317","author":"Vanover","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2026.130662_bb0045","article-title":"A phase 2, randomized, double-blind, placebo-controlled study of adjunctive pimavanserin in patients with major depressive disorder and an inadequate response to therapy (CLARITY)","volume":"24","author":"Fava","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bmcl.2026.130662_bb0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/da.23017","article-title":"Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: a secondary analysis","volume":"37","author":"Freeman","year":"2020","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bmcl.2026.130662_bb0055","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.npp.1300762","article-title":"The selective 5-HT2A receptor antagonist m100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine","volume":"30","author":"Marek","year":"2005","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.bmcl.2026.130662_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00221-013-3434-3","article-title":"5-HT2A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system","volume":"226","author":"Quesseveur","year":"2013","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.bmcl.2026.130662_bb0065","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ijnp\/pyab040","article-title":"A complex impact of sys-temically administered 5-HT2A receptor ligands on conditioned fear","volume":"24","author":"Hags\u00e4ter","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bmcl.2026.130662_bb0070","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/ci400742s","article-title":"Identification of novel serotonin transporter compounds by virtual screening","volume":"54","author":"Gabrielsen","year":"2014","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2026.130662_bb0075","series-title":"Heterocyclic Chemistry","author":"Joule","year":"2000"},{"key":"10.1016\/j.bmcl.2026.130662_bb0080","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1021\/jo00430a041","article-title":"Selective carbon-carbon bond formation via transition metal catalysis. 3. A highly selective synthesis of unsymmetrical biaryls and diarylmethanes by the nickel- or palladium-catalyzed reaction of aryl- and benzylzinc derivatives with aryl halides","volume":"42","author":"Negishi","year":"1977","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2026.130662_bb0085","article-title":"Esteve trias c, soca pueyo l","volume":"017096","author":"Bernat","year":"2007","journal-title":"Eastwood PR Pyrazine derivatives useful as adenosine receptor antagonists International patent WO"},{"key":"10.1016\/j.bmcl.2026.130662_bb0090","series-title":"Protective Groups in Organic Synthesis","author":"Greene","year":"1999"},{"key":"10.1016\/j.bmcl.2026.130662_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/00304948.2013.743751","article-title":"Ammonium chloride-catalyzed synthesis of benzofused heterocycles from o-substituted anilines and orthoesters","volume":"45","author":"Fortenberry","year":"2013","journal-title":"Org Prep Proced Intl"},{"key":"10.1016\/j.bmcl.2026.130662_bb0100","series-title":"Anti-fibrotic compounds. International patent WO 144620","author":"Miller","year":"2018"},{"key":"10.1016\/j.bmcl.2026.130662_bb0105","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/jo00820a603","article-title":"Formylation of amines with phenyl formate","volume":"36","author":"Yale","year":"1971","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmcl.2026.130662_bb0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/00304940509354950","article-title":"Synthesis of substituted 1,3,4-thiadiazoles using lawessons reagent","volume":"37","author":"Gierczyk","year":"2005","journal-title":"Org Prep & Proc Int"},{"key":"10.1016\/j.bmcl.2026.130662_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/acs.joc.0c01758","article-title":"Improvement in the palladium-catalyzed miyaura borylation reaction by optimization of the base: scope and mechanistic study","volume":"86","author":"Barroso","year":"2021","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2026.130662_bb0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1351\/pac199163030419","article-title":"Synthetic studies via the cross-coupling reaction of organoboron derivatives with organic halides","volume":"63","author":"Suzuki","year":"1991","journal-title":"Pure & Appl Chem"},{"key":"10.1016\/j.bmcl.2026.130662_bb0125","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1021\/cr00039a007","article-title":"Palladium-catalyzed cross-coupling reactions of organoboron compounds","volume":"95","author":"Miyaura","year":"1995","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2026.130662_bb0130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/anie.198605081","article-title":"The palladium-catalyzed cross-coupling reactions of organotin reagents with organic electrophiles [new synthetic methods (58)]","volume":"25","author":"Stille","year":"1986","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2026.130662_bb0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1067\/mcp.2003.28","article-title":"Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers","volume":"73","author":"Skinner","year":"2003","journal-title":"Clin Pharm & Ther"},{"key":"10.1016\/j.bmcl.2026.130662_bb0140","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.bmcl.2007.01.020","article-title":"N-benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidine-3-amines as selective dual serotonin\/noradrenaline reuptake inhibitors","volume":"17","author":"Fish","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130662_bb0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1476-5381.2009.00578.x","article-title":"Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT)","volume":"159","author":"Fox","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130662_bb0150","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(24)36840-5","article-title":"Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats","volume":"282","author":"Willins","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"10.1016\/j.bmcl.2026.130662_bb0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130662_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1476-5381.1991.tb12392.x","article-title":"Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents","volume":"104","author":"Njung\u2019e","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130662_bb0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00213-005-0170-9","article-title":"ACP-103, a 5-HT2A\/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens","volume":"183","author":"Li","year":"2005","journal-title":"Psychopharmacology"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:14:32Z","timestamp":1778789672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S0960894X26001290"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130662","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel SSRIs for a combination-treatment with pimavanserin","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130662"}}